CDKN2B-AS1 and breast carcinoma: The relative expression of different lncRNAs studied such as ANRIL (3.83 fold), TUG-1 (7.64 fold), UCA-1 (7.82 fold), and HIT (3.46 fold) (Figure 1) and their association with clinical and pathological characteristics among the breast cancer patients (Tables 2, , –5) was obtained.